Happiness Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Epoch Biodesign
25 Mar 2026
Epoch Biodesign raises £9m in funding from lululemon and leading VCs for enzymatic nylon recycling
Epoch Biodesign develops enzymatic recycling technology that converts waste nylon materials back into their original chemical components. It enables manufacturers to produce new nylon without using virgin feedstock, helping apparel and automotive companies reduce reliance on raw materials.
Epoch Biodesign
5 Mar 2025
Epoch Biodesign raises £14m Series A led by Extantia Capital to scale plastic-eating enzyme technology
Epoch Biodesign uses engineered enzymes to break down plastic waste into reusable chemical building blocks, enabling higher-quality recycling at industrial scale.
Happiness Capital
- 1(12 months)
- happinesscapital.com
- Update Information
More venture news
- 25 Jun 2026
HR DuoHR Duo secures £1.4m in funding led by Puma Growth Partners to build workforce management platform for frontline-heavy SMEs
EquityHR - 23 Jun 2026
LabCycleLabCycle raises £180k from British Design Fund to scale circular recycling system for contaminated laboratory plastics
EquityClimate - 19 Jan 2026
LabCycleLabCycle unlocks funding from Angel Academe to solve the circular recycling of laboratory plastic waste
EquityClimate
